Clinical Trial Update: An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling [Phase 1]

View source ↗

Summary

An open-label Phase 1 study evaluating N-acetylcysteine for pathological gambling has completed, providing initial safety and tolerability data along with preli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pathological Gambling

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Minnesota | Conditions: Pathological Gambling | Phase 1 | Status: COMPLETED